Free Shipping On Orders Over $1,000!

Visinin-Like Protein 1 (VSNL1) Antibody

Applications

  • WB
  • IHC
  • ICC

Reactivity

  • Human
  • Mouse
  • Rat
Overview
Catalog # bsm-70313M
Product Name Visinin-Like Protein 1 (VSNL1) Antibody
Applications WB, IHC, ICC
Specificity Specific for endogenous levels of the ~22 kDa VSNL1 protein.
Reactivity Human, Mouse, Rat
Specifications
Conjugation Unconjugated
Host Mouse
Source Recombinant human VSNL1 purified from E. coli.
Clonality Monoclonal
Clone # 2D11
Isotype IgG1
Concentration Lot Dependent
Purification Purified by Protein G.
Storage Buffer PBS + 10 mM NaN3.
Storage Condition Recommended that the undiluted antibody be aliquoted into smaller working volumes (10-30 uL/vial depending on usage) upon arrival and stored long term at -20° C or -80° C, while keeping a working aliquot stored at 4° C for short term. Avoid freeze/thaw cycles. Stable for at least 1 year.
Target
Gene ID 7447
Swiss Prot P62760
Synonyms 21 kDa CABP antibody, Hippocalcin like protein 3 antibody, Hippocalcin-like protein 3 antibody, HLP 3 antibody, HLP3 antibody, HPCAL 3 antibody, HPCAL3 antibody, HUVISL1 antibody, Neural visinin-like protein 1 antibody, Neural visinin-like type 1 protein antibody, Neurocalcin alpha antibody, NVL 1 antibody, NVL1 antibody, Nvp1 antibody, OZ1 antibody, Ratnvp1 antibody, VILIP antibody, VILIP1 antibody, VILIP-1 antibody, Visinin antibody, Visinin like 1 antibody, Visinin like protein 1 antibody, Visinin-like protein 1 antibody, VISL 1 antibody, VISL1 antibody, VISL1_HUMAN antibody, VLP-1 antibody, Vnsl1 antibody, Vsnl1 antibody
Background Visinin-like protein 1 (VSNL1), also known as VILIP1, is a calcium sensor protein expressed exclusively in neurons. Highest levels of VSNL1 expression are found in cerebellar Purkinje cells. VSNL1 has been implicated in the modulation of cell signaling cascades via regulation of adenyl cyclase activity (Braunewell et al., 1997). Additionally, VSNL1 has been associated with amyloid plaques and neurofibrillar tangles in Alzheimer’s disease (Schnurra et al., 2001).
Application Dilution
WB 1:300-5000
IHC
ICC 1:100-500